Angelovska, Bistra and Drakalska, Elena (2014) Market characteristics of innovative medicines in the Republic of Macedonia. In: First Macedonian and Fourth Adriatic Congress on Pharmacoeconomics and Outcomes Research, 24-27 Apr 2014, Ohrid, Macedonia.
Preview |
Text
ABSTRACT BOOK.pdf Download (2MB) | Preview |
![[thumbnail of Poster _ECIS2013.ppt]](/style/images/fileicons/slideshow.png) |
Slideshow
Poster _ECIS2013.ppt Download (485kB) |
Abstract
The competition between innovative and generic pharmaceutical companies intensified in the last decades. The models created by innovative pharmaceutical industries rest on market exclusivity, higher medicines prices and patent protection system. Republic of Macedonia has a limited medicines budget, and its healthcare policies aim to save on medicines supplies. The legislation in the Republic of Macedonia is constantly modified due to the harmonisation with the European regulation. The country intends to allow the entry and use of innovative medicines, especially for first- and second-line therapy. In this study, we aim to
analyze the current legislation (legal acts, bylaws, price methodology) and describe the circumstances that lead to innovative medicines’ market entry.
| Item Type: | Conference or Workshop Item (Poster) |
|---|---|
| Subjects: | Medical and Health Sciences > Other medical sciences |
| Divisions: | Faculty of Medical Science |
| Depositing User: | Bistra Angelovska |
| Date Deposited: | 01 Jul 2014 13:00 |
| Last Modified: | 01 Jul 2014 13:00 |
| URI: | https://eprints.ugd.edu.mk/id/eprint/9952 |
Actions (login required)
 |
View Item |